10.6084/m9.figshare.6391322.v1
Chakrapani Balijepalli
Chakrapani
Balijepalli
Rohan Shirali
Rohan
Shirali
Prashanth Kandaswamy
Prashanth
Kandaswamy
Anastasia Ustyugova
Anastasia
Ustyugova
Egon Pfarr
Egon
Pfarr
Søren S. Lund
Søren S.
Lund
Eric Druyts
Eric
Druyts
Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons
Adis Journals
2018
Cardiovascular outcomes
DPP-4 inhibitors
Empagliflozin
Network meta-analysis
Saxagliptin
Sitagliptin
2018-06-07 15:52:35
Figure
https://adisjournals.figshare.com/articles/figure/Cardiovascular_Safety_of_Empagliflozin_Versus_Dipeptidyl_Peptidase_4_DPP-4_Inhibitors_in_Type_2_Diabetes_Systematic_Literature_Review_and_Indirect_Comparisons/6391322
<p><b>Article full text</b></p><p><br></p><p>The full text of this article can
be found here<b>. </b><a href="https://link.springer.com/article/10.1007/s13300-018-0456-7">https://link.springer.com/article/10.1007/s13300-018-0456-7</a></p><p></p><p><br></p><p><b>Provide enhanced content for this
article</b></p><p><br></p><p>If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact <a href="http://www.medengine.com/Redeem/âmailto:adisrapidplus@springer.comâ"><b>adisrapidplus@springer.com</b></a>.</p><p><br></p><p>The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.</p><p><br></p><p>Other enhanced features include,
but are not limited to:</p><p><br></p><p>• Slide decks</p><p>• Videos and animations</p><p>• Audio abstracts</p><p>
</p><p>• Audio slides</p>
<p><b> </b></p>